- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01591707
Evaluating a Social and Communication Intervention for Preschoolers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In Phase 4, KKI staff trained Delaware preschool teachers to serve as model coaches and educators through the Delaware Autism Program. Families whose children were enrolled in participating classrooms were consented through DAP using the school's consent to be videotaped. Any families who did not consent for their child to be videotaped for this training received the nonparticipant consent form currently utilized in this study and staff videotaping took every effort to keep those children out of frame when taping. This cohort involved KKI study team members training 1-2 coaches, who then trained five Delaware school teachers. The IES model was implemented in the teacher's classrooms (n= 5-10 students participating in each classroom; 20-40 children total).
In the current phase of the study, Phase 5 and 6, KKI study team members will continue the evaluation of the IES model, by testing the efficacy of the intervention model in a larger sample (Phase 5) and then analyzing the corresponding data (Phase 6). The larger efficacy study (phase 5) will be conducted on teachers and students recruited from public school districts in Maryland, Delaware, and Pennsylvania using the same IES model and recruitment methods in the previous phases.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Brennen School
-
-
Maryland
-
Baltimore, Maryland, United States, 21211
- Kennedy Krieger Institute/Howard County Public Schools
-
-
Pennsylvania
-
Media, Pennsylvania, United States, 19063
- Elwyn Early Childhood Services
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
For Teachers:
- Work in an ASD preschool classroom within a cooperating Baltimore County Public School.
For Children:
- Meet Autism Diagnostic Observation Schedule-Generic (ADOS; Lord et al., 2002) and expert clinical judgment criteria for ASD
- Have an IQ or Developmental Quotient of at least 40 based on the Early Learning Composite from the Mullen Scales of Early Learning (Mullen, 1995)
- Be enrolled in a participating Baltimore County Public School ASD preschool classroom
- Be between the ages of 3 and 6 and enrolled in a participating ASD preschool classroom.
Exclusion Criteria:
Children and educators may be taken out of the study if they:
- Are unable to comply with the study protocol
- Change schools due to relocation
Children may also be taken out of this study if they:
- Sustain a head injury or other serious physical injury during the study
- Are not being brought in for testing as designated in the protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ISC+PRT Intervention
For the duration of at least one school year children will receive 45-90 minutes of intervention in the classroom in an attempt to increase social and communication skills.
|
Teachers will be trained to implement an intervention in preschool ASD classrooms that provides a learning environment in which social and communication skills are focused on.
|
No Intervention: Instruction As Usual
For the duration of at least one year children will receive the typical classroom instruction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in educator instruction to meet fidelity of intervention.
Time Frame: approximately 4-, 8-, 12-, 16-, 20-, 24-, 28-, 32-, and 36-weeks into the intervention
|
Fidelity will be monitored throughout the duration of the intervention by KKI staff to assess the quality and consistency with which educators implement the intervention.
|
approximately 4-, 8-, 12-, 16-, 20-, 24-, 28-, 32-, and 36-weeks into the intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Baseline Autism Diagnostic Observation Schedule
Time Frame: 9 months into treatment
|
9 months into treatment
|
Change in Baseline Mullen Scales of Early Learning
Time Frame: 9 months into treatment
|
9 months into treatment
|
Change in Child's Baseline Spontaneous Imitation Task
Time Frame: 9 months into treatment
|
9 months into treatment
|
Change in Child Classroom-based Social Communication Performance
Time Frame: 9 months into treatment
|
9 months into treatment
|
Change in parent perception of child behavior as recorded by the Autism Composite score of the PDDBI (parent version)
Time Frame: 9 months into treatment
|
9 months into treatment
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NA_00073501
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on ISC+PRT Intervention
-
Stanford UniversityAnonymous DonorRecruitingAutism Spectrum Disorder | Autism | ASDUnited States
-
Cyto Therapeutics Pty LimitedUnknownParkinson DiseaseAustralia
-
Philips Electronics Nederland B.V. acting through...Research America Inc; QserveCompletedCognitive Functioning of Healthy IndividualsUnited States
-
Philips Electronics Nederland B.V. acting through...Factory CRO; Research America Inc; QserveCompletedCognitive Functioning of Healthy IndividualsUnited States
-
Stanford UniversityCompletedAutistic Disorder | Developmental DisabilitiesUnited States
-
Proteon TherapeuticsUniversity of California, San FranciscoCompletedPeripheral Artery DiseaseUnited States
-
Proteon TherapeuticsCompletedChronic Kidney DiseaseUnited States
-
Proteon TherapeuticsWithdrawnPeripheral Artery DiseaseUnited States
-
Proteon TherapeuticsCompletedChronic Kidney DiseaseUnited States
-
Proteon TherapeuticsCompletedChronic Kidney DiseaseUnited States